Literature DB >> 19606418

Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia.

Shenghua Gu1, Jiye A, Guangji Wang, Weibin Zha, Bei Yan, Ying Zhang, Hongcan Ren, Bei Cao, Linsheng Liu.   

Abstract

The measurement of metabolites in tissues is of great importance in metabonomic research in the biomedical sciences, providing more relevant information than is available from systemic biofluids. The liver is the most important organ/tissue for most biochemical reactions, and the metabolites in the liver are of great interest to scientists. To develop an optimized extraction method and comprehensive profiling technique for liver metabolites, organic solvents of various compositions were designed using design of experiments to extract metabolites from the liver, and the metabolites were profiled by gas chromatography/time-of-flight mass spectrometry (GC/TOF-MS). The resolved peak areas were processed by principle components analysis, partial least-squares projections to latent structures, and discriminant analysis. The results suggest the highest extraction efficiency was for methanol-water, which maximized the majority of GC/TOF-MS responses. The optimal solvent was applied to extract metabolites in liver of hyperlipidemia hamster and the control. The GC/TOF-MS profiles of liver metabolites showed obvious differences between hyperlipidemic hamsters and controls. A comparison of liver and serum data from the same animals identified common biomarkers and presented complementary information. Our results suggest that liver metabonomics is a valuable technique and that the combined analysis of systematic biofluids and local tissues is meaningful and complementary, recovering more comprehensive metabonomic data than either analysis alone. 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 19606418     DOI: 10.1002/bmc.1279

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  10 in total

1.  The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity.

Authors:  H-H Chen; Y J Tseng; S-Y Wang; Y-S Tsai; C-S Chang; T-C Kuo; W-J Yao; C-C Shieh; C-H Wu; P-H Kuo
Journal:  Int J Obes (Lond)       Date:  2015-04-24       Impact factor: 5.095

2.  Deletion of protein kinase Cε in mice has limited effects on liver metabolite levels but alters fasting ketogenesis and gluconeogenesis.

Authors:  K Raddatz; G Frangioudakis; B Diakanastasis; B M Liao; M Leitges; C Schmitz-Peiffer
Journal:  Diabetologia       Date:  2012-07-20       Impact factor: 10.122

3.  Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats.

Authors:  Li-fang Zhang; Ling-sheng Liu; Xiao-man Chu; Hao Xie; Li-juan Cao; Cen Guo; Ji-ye A; Bei Cao; Meng-jie Li; Guang-ji Wang; Hai-ping Hao
Journal:  Acta Pharmacol Sin       Date:  2014-01-20       Impact factor: 6.150

4.  GC-TOF/MS-based metabolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats.

Authors:  Bo Ma; Qi Zhang; Guang-ji Wang; Ji-ye A; Di Wu; Ying Liu; Bei Cao; Lin-sheng Liu; Ying-ying Hu; Yong-lu Wang; Ya-ya Zheng
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

5.  A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine.

Authors:  Shenghua Gu; Bei Cao; Runbin Sun; Yueqing Tang; Janice L Paletta; Xiaolei Wu; Xiao-Lei Wu; Linsheng Liu; Weibin Zha; Chunyan Zhao; Yan Li; Jason M Ridlon; Jason M Radlon; Phillip B Hylemon; Huiping Zhou; Jiye Aa; Guangji Wang
Journal:  Mol Biosyst       Date:  2014-11-20

Review 6.  Optimizing Mass Spectrometry Analyses: A Tailored Review on the Utility of Design of Experiments.

Authors:  Elizabeth S Hecht; Ann L Oberg; David C Muddiman
Journal:  J Am Soc Mass Spectrom       Date:  2016-03-07       Impact factor: 3.109

7.  Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats.

Authors:  Qiu-yu Xu; Yin-hui Liu; Qi Zhang; Bo Ma; Zhen-dong Yang; Lei Liu; Di Yao; Guang-bo Cui; Jing-jing Sun; Zi-mei Wu
Journal:  Acta Pharmacol Sin       Date:  2014-09-15       Impact factor: 6.150

8.  Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia.

Authors:  Jiahua Guo; Yonghong Yong; Jiye Aa; Bei Cao; Runbin Sun; Xiaoyi Yu; Jingqiu Huang; Na Yang; Lulu Yan; Xinxin Li; Jing Cao; Nan Aa; Zhijian Yang; Xiangqing Kong; Liansheng Wang; Xuanxuan Zhu; Xiaohui Ma; Zhixin Guo; Shuiping Zhou; He Sun; Guangji Wang
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

9.  Serum lysophospholipid levels are altered in dyslipidemic hamsters.

Authors:  Susana Suárez-García; Antoni Caimari; Josep Maria Del Bas; Manuel Suárez; Lluís Arola
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

10.  Plasma metabolomics of children with aberrant serum lipids and inadequate micronutrient intake.

Authors:  Katherine J Li; NaNet Jenkins; Gary Luckasen; Sangeeta Rao; Elizabeth P Ryan
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.